Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Qureshi, Asaf A ^a   Reis, Julia C ^a   Papasian, Christopher J ^a   Morrison, David C ^a   Qureshi, Nilofer ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b School of Pharmacy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOTRIENOL; CHYMOTRYPSIN; CORTICOSTERONE; CORTICOTROPIN; CYTOKINE; DELTA TOCOTRIENOL; GAMMA TOCOTRIENOL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A; ACYL COENZYME A; CORTICOSTEROID; ENZYME INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OXIDOREDUCTASE; PROTEASOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG ISOLATION; DRUG PURIFICATION; FEMALE; GENE EXPRESSION; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CARDIOVASCULAR DISEASE; CELL LINE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MUSCLE; RABBIT;

MURINAE; MUS; ORYCTOLAGUS CUNICULUS;

ACYL COENZYME A; ADRENAL CORTEX HORMONES; ANIMALS; CARDIOVASCULAR DISEASES; CELL LINE; CYTOKINES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MUSCLES; OXIDOREDUCTASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RABBITS; TOCOTRIENOLS;

EID: 78650106544     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-143     Document Type: Article

References (35)

1. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodobacter sphaeroides is an LPS antagonist and an inducer of corticosteroids. N Qureshi K Takayama J Hofman SH Zuckerman, Bacterial endotoxin: Recognition and effector mechanisms Elsevier Science Publishers BV, Levin J, Alving CR, Munford RS, Stutz PI, 1993 361 371
2. Septic shock Pathogenesis. MP Glauser G Zanetti JD Baumgartner J Cohen, Lancet 1991 338 732 736 10.1016/0140-6736(91)91452-Z 1679876
3. In vivo inhibition of lipopolysaccharides-Induced lethality and tumor necrosis factor synthesis by Rhodobactor sphaeroides Diphosphoryl lipid A is dependent on corticosterone induction. SH Zuckerman N Qureshi, Infect Immun 1992 60 2581 2587 1612727
4. Atherosclerosis: An inflammation diseases. R Ross, N Engl J Med 1999 340 115 126 10.1056/NEJM199901143400207 9887164
5. Interactive role of infection, inflammation and traditional risk factores in atherosclerosis and coronary artery disease. JL Mehta TGP Saldeen K Rand, J Am Coll Cardiol 1998 31 1217 1225 10.1016/S0735-1097(98)00093-X 9581711
6. Novel inflammatory markers of coronary risk. Theory versus practice. P Libby PM Ridker, Circulation 1999 100 1148 1150 10484532
7. Atherogenesis and inflammation. P Libby GK Hansson JS Pober, Molecular basis of cardiovascular disease Phildelphia WB Saunder Company, Chein KR, 1999
8. The proteasome: A central regulator of inflammation and macrophage function. N Qureshi SN Vogel CV Van Way III CJ Papasian AA Qureshi DC Morrison, Immunological Research 2005 31 3 243 260 10.1385/IR:31:3:243 (Pubitemid 40628961)
9. Novel tocotrienol of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE deficient mice. AA Qureshi WA Salser R Parmer EE Emeson, J Nutrition 2001 131 2606 2618
10. Isolation and structural identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant and antitumor properties. AA Qureshi H Mo L Packer DM Peterson, J Agr Food Chem 2000 48 3130 3140 10.1021/jf000099t
11. Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. SG Yu AM Thomas A Gapor B Tan N Qureshi AA Qureshi, Lipids 2006 41 453 461 10.1007/s11745-006-5119-1 16933790
12. 25) of rice bran in hypercholesterolemic humans. AA Qureshi SA Sami WA Salser FA Khan, Atherosclerosis 2002 161 199 207 10.1016/S0021-9150(01)00619-0 11882333
13. 25) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. AA Qureshi SA Sami WA Salser FA Khan, J Nutr Biochem 2001 12 318 329 10.1016/S0955-2863(01)00144-9 11516635
14. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. AA Qureshi DM Peterson JO Hasler-Rapacz J Rapacz, J Nutr 2001 131 223 230 11160537
15. Tocotrienols inhibits the growth of human breast cancer cells irrespective of estrogen receptor status. K Nesaretnam R Stephen R Dils P Darbre, Lipids 1998 33 5 461 469 10.1007/s11745-998-0229-3 9625593
16. -Tocopherol attenuates the impact of -tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. AA Qureshi BC Pearce RM Nor A Gapor DM Peterson CE Elson, J Nutr 1996 126 389 394 8632210
17. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. EA Serbinova L Packer, Methods Enzymology 1994 234 354 366 full-text
18. Tocotrienols, novel hypocholesterolemic agents with Antioxidant properties. N Qureshi AA Qureshi, Vitamin E in health and disease Marcel Decker: New York, Packer L, Fuchs J, 1993 247 268
19. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase. RA Parker BC Pearce RW Clark DA Gordon JJK Wright, J Biol Chem 1993 268 11230 11238 8388388
20. Hypocholesterolemic activity of synthetic and natural tocotrienols. BC Pearce RA Parker ME Deason AA Qureshi JJK Wright, J Med Chem 1992 35 3595 3606 10.1021/jm00098a002 1433170
21. Effect of dietary supplementation of tocotrienols and tocopherols on serum lipids in hamster. HT Khor, Nutr Res 1992 16 1391 1401
22. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. E Serbinova V Kagan D Han L Packer, Free Radical Biol Med 1991 10 5 263 275 10.1016/0891-5849(91)90033-Y
23. Characterization of potent neuroprotective properties of the natural vitamin E -tocotrienol. S Khanna S Roy NL Parinandi M Maurer CK Sen, J Neurochemistry 2007 98 1474 1486 10.1111/j.1471-4159.2006.04000.x
24. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. A Theriault JT Chao A Gapor, Atherosclerosis 2002 160 21 30 10.1016/S0021-9150(01)00540-8 11755919
25. Structural analysis of the lipid A derived from the lipopolysaccharide of Brucella abortus. N Qureshi K Takayama U Seydel R Wong RJ Cotter PK Agrawal CA Bush R Kurtz DT Berman, J Endotoxin Res 1994 1 137 148
26. Complete structural determination of lipopolysaccharides obtained from deep rough mutant of Escherichia coli: purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. N Qureshi K Takayama P Mascagni J Honovich R Wong RJ Cotter, J Biol Chem 1988 263 11971 11976 3136169
27. Key Inflammatory signaling pathways are regulated by the proteasome. J Shen J Reis DC Morrison C Papasian R Sreekumar C Kolbert AA Qureshi SN Vogel N Qureshi, Shock 2006 25 472 484 10.1097/01.shk.0000209554.46704.64 16680012
28. The Proteasome as a LPS-binding protein in macrophages: Toxic lipopolysaccharide activates the proteasome complex. N Qureshi PY Perera G Splitter DC Morrison SN Vogel, J Immunol 2003 171 1515 1525 12874245
29. Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogenactivated protein kinases in macrophages. J Shen JJ Gao G Zhang X Tan DC Morrison CJ Papasian SN Vogel N Qureshi, Shock 2006 25 594 599 10.1097/01.shk.0000209555.46704.2d 16721267
30. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. F Denizot R Lang, J Immunol Methods 1986 89 271 277 10.1016/0022-1759(86)90368-6 3486233
31. Role of the 26 S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase, an integral endoplasmic reticulum membrane protein. RY Hampton RG Gardner J Rine, Mol Biol Cell 1996 7 2029 2044 8970163
32. Insig-dependent ubiquitination and degradation of 3-hydroxy-3- methylglutaryl coenzyme A reductase stimulated by - and -tocotrienols. BL Song RA DeBosed-Boyed, J Biol Chem 2005 281 35 25054 25061 10.1074/jbc.M605575200
33. The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase. T Ravid R Doolman R Avner D Harats J Roitelman, J Biol Chem 2000 275 35 840 847 10625616
34. Inhibition versus induction of apoptosis by proteasome inhibitors depend on concentration. KI Lin RF Baraban RF Reichard EJ Corey SL Schreiber, Cell Death and Differentiation 1998 5 577 583 10.1038/sj.cdd.4400384 10200512
35. A -lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. G Fenteany RF Standaert GA Reichard EJ Corey SL Schreiber, Proc Natl Acad Sci USA 1994 91 3358 3362 10.1073/pnas.91.8.3358 8159752